Contraindications
As primary treatment of status asthmaticus or acute episodes of asthma requiring intensive measures (inhalation).
|
Special Precautions
Patient w/ bacterial (e.g. active or quiescent pulmonary TB), fungal, parasitic, and viral (e.g. chickenpox, measles, ocular herpes simplex) infection, DM, gastro-duodenal ulcer, serious arterial HTN, myasthenia gravis, MI, osteoporosis, hypoadrenalism, glaucoma, cataract, seizure disorder, depression, previous steroid-related psychosis, recent nasal septal ulcers, trauma, and surgery. Renal and hepatic (e.g. cirrhosis) impairment. Childn, Pregnancy and lactation. Patient Counselling Rinse mouth thoroughly after inhalation. Monitoring Parameters Monitor growth annually during long term use in childn. Assess for ocular changes, signs and symptoms of adrenal insufficiency, and oral candidiasis.
|
Adverse Reactions
Oral candidiasis, hoarseness, cough, epistaxis, irritation and dryness of nose and throat, unpleasant taste and smell, nasopharyngitis, rhinitis, sneezing, paradoxical bronchospasm w/ wheezing, dyspnoea; hypersensitivity (e.g. rash, urticaria, pruritus, erythema, angioedema); impaired wound healing; headache, vertigo, tremor; adrenal suppression. Rarely, Cushing's syndrome, decreased bone mineral density, psychomotor hyperactivity, aggression, irritability, anxiety, depression, sleep disorder, suicidal ideation.
|
ATC Classification
A07EA07 - beclometasone ; Belongs to the class of corticosteroids acting locally. Used in the treatment of intestinal inflammation.
R01AD01 - beclometasone ; Belongs to the class of topical corticosteroids used for prophylaxis and treatment of allergic rhinitis. D07AC15 - beclometasone ; Belongs to the class of potent (group III) corticosteroids. Used in the treatment of dermatological diseases. R03BA01 - beclometasone ; Belongs to the class of other inhalants used in the treatment of obstructive airway diseases, glucocorticoids. |